Home›Stock Screener›Indegene›Quarterly Results

Indegene Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹80 Cr
QMar 2026
Quarterly Results

In Mar 2026, Indegene (INDGN) reported revenue ₹1,014 Cr and net profit ₹80 Cr — revenue +29.8% YoY. Analyse Indegene ownership structure to track promoter, FII and institutional holdings.

INDGN Quarterly Results — Revenue, Profit & EPS Highlights

Indegene latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View INDGN price range for the annual high/low range and current price position.

  • Revenue of ₹1,014 Cr in Mar 2026 (-7.1% vs Jun 2026, +29.8% vs Mar 2025)
  • Net Profit of ₹80 Cr in Mar 2026 (-31.0% vs Jun 2026, -32.2% vs Mar 2025)
  • EBITDA of ₹154 Cr in Mar 2026 (-24.1% vs Jun 2026)
  • Operating Margin of 14.0% in Mar 2026 (-2.0pp vs Jun 2026)
  • Earnings Per Share of ₹3.32 in Mar 2026 (-31.4% vs Jun 2026)

Indegene Quarterly Results — Revenue, EBITDA, Net Profit & EPS

INDGN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 1,014 1,092 824 781 783 -7.1% 29.8%
Net Profit (₹ Cr) 80 116 102 118 116 - -
EBITDA (₹ Cr) 154 203 160 173 177 - -
EPS (₹) 3.32 4.84 4.26 4.91 4.86 - -
Operating Margin (%) 14.0% 16.0% 17.0% 20.0% 20.0% - -

INDGN Share Price Trend — 1-Year Movement Across Quarterly Results

Indegene 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit INDGN stock price BSE.

Profitability Ratios

Profit Margin 7.9%
EBITDA Margin 15.2%
Operating Margin 14.0%
ROE (Annual) 10.2%

Balance Sheet Highlights

Total Assets ₹4,620 Cr
Total Equity ₹3,139 Cr
Current Assets ₹2,618 Cr
Current Liabilities ₹395 Cr

Cash Flow Analysis

Operating Cash Flow ₹651 Cr
Investing Cash Flow ₹-508 Cr
Financing Cash Flow ₹-83 Cr
Net Cash Flow ₹60 Cr

Current Market Data

Current Price ₹600.10
Exchange NSE
Last Updated Sep 18, 2026

Revenue Trend (₹ Cr)

Mar 2025 781
Sept 2025 824
Jun 2026 1,092
Mar 2026 1,014

Net Profit Trend (₹ Cr)

Mar 2025 118
Sept 2025 102
Jun 2026 116
Mar 2026 80

Operating Margin Trend (%)

Mar 2025 20.0%
Sept 2025 17.0%
Jun 2026 16.0%
Mar 2026 14.0%

INDGN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Indegene latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹441,477.63 Cr 1837.3 15,018 2,710 -5.6% - 18.0% 162.6
Divis Laboratories
Mar 2026 		₹247,469.81 Cr 9375.0 2,986 751 -5.0% - 25.2% 331.2
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4840.0 4,111 364 +27.7% +42.2% 8.9% 420.5
Cipla
Mar 2026 		₹112,654.03 Cr 1394.5 6,612 543 -9.3% - 8.2% 203.0
Zydus Life Science
Mar 2026 		₹112,607.65 Cr 1160.0 7,569 1,341 -4.3% - 17.7% 91.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores